OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2024
(4)
2025
(3)
2022
(3)
2021
(3)
2023
(2)
2026
(1)
2020
(1)
2017
(1)
2014
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
FSRT vs. SRS in Brain Metastases-Differences in Local Control and Radiation Necrosis-A Volumetric Study.
Not available
S-EPMC7554610
|
biostudies-literature
Cite
Impaired maturation of resting-state connectivity in anorexia nervosa from adolescence to adulthood: differential mechanisms of consummatory vs. anticipatory responses through a symptom provocation paradigm.
Not available
S-EPMC11541234
|
biostudies-literature
Cite
Deep learning for automatic head and neck lymph node level delineation provides expert-level accuracy.
Not available
S-EPMC9978473
|
biostudies-literature
Cite
A Longitudinal Investigation of Prediabetes, Diabetes, HbA1c and Cognitive Trajectories Among Cognitively Unimpaired Individuals.
Not available
S-EPMC12931372
|
biostudies-literature
Cite
SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway.
Not available
S-EPMC3961532
|
biostudies-literature
Cite
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients.
Not available
S-EPMC8151445
|
biostudies-literature
Cite
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status.
Not available
S-EPMC11868123
|
biostudies-literature
Cite
MCU controls melanoma progression through a redox-controlled phenotype switch
Not available
S-SCDT-EMBOR-2022-54746-T
|
biostudies-other
Cite
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591
|
biostudies-literature
Cite
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets